AKT1 and prostate carcinoma: Moreover, it has been shown that cAMP-PKA/PI3K-Akt signaling pathway, activated in prostate cancer cells by the binding of PGE2 to its EP3 receptor, is involved in PC-3 cells proliferation [68].